Insmed
INSM
$24.80
Share price
-0.48%
Change (1 day)
28.83%
Change (1 year)
Categories
Insmed (INSM) - Net assets
Net assets on the balance sheet as of December 2023 : -$0.34 B
According to Insmed's latest financial reports the company has -$0.34 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Insmed - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-0.34 B | -477.4% |
| 2022-12-31 | $87.95 M | -78.57% |
| 2021-12-31 | $0.41 B | 48.78% |
| 2020-12-31 | $0.27 B | 5.43% |
| 2019-12-31 | $0.26 B | 25.64% |
| 2018-12-31 | $0.20 B | -42.32% |
| 2017-12-31 | $0.36 B | 133.72% |
| 2016-12-31 | $0.15 B | -50.44% |
| 2015-12-31 | $0.31 B | 67.37% |
| 2014-12-31 | $0.18 B | 29.94% |
| 2013-12-31 | $0.14 B | 18.57% |
| 2012-12-31 | $0.12 B | -9.97% |
| 2011-12-31 | $0.13 B | -30.37% |
| 2010-12-31 | $0.19 B | 55.63% |
| 2009-12-31 | $0.12 B | -4489.44% |
| 2008-12-31 | $-2.83 M | -124.57% |
| 2007-12-31 | $11.48 M | -17.23% |
| 2006-12-31 | $13.88 M | 31.83% |
| 2005-12-31 | $10.52 M | 45.53% |
| 2004-12-31 | $7.23 M | -72.41% |
| 2003-12-31 | $26.22 M | 11.82% |
| 2002-12-31 | $23.44 M | -60.72% |
| 2001-12-31 | $59.69 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $39.75 B | -12,077.48% | 🇨🇭 Switzerland |
 Gilead Sciences GILD | $22.74 B | -6,953.70% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $17.58 B | -5,396.53% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $0.85 B | -358.90% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | -$0.17 B | -50.60% | 🇺🇸 USA |
 Array Technologies ARRY | $0.61 B | -283.93% | 🇺🇸 USA |